Antihypertensive drug associated angioedema: effect modification by race/ethnicity

• Marsha E. ReichmanUnited States Food and Drug Administration
• Michael WerneckeAcumen (United States)
• David J. GrahamUnited States Food and Drug Administration
• Jiemin LiaoAcumen (United States)
• John YapUnited States Food and Drug Administration
• Yoganand ChillarigeAcumen (United States)
• Mary Ross SouthworthUnited States Food and Drug Administration
• Stephine KeetonUnited States Food and Drug Administration
• Margie R. GouldingUnited States Food and Drug Administration
• Katrina MottUnited States Food and Drug Administration
• Jeffrey A. KelmanCenters for Medicare and Medicaid Services